Determination of variability due to biological and technical variation in urinary extracellular vesicles as a crucial step in biomarker discovery studies

被引:21
作者
Oeyen, Eline [1 ,2 ]
Willems, Hanny [1 ,2 ]
'T Kindt, Ruben [3 ]
Sandra, Koen [3 ]
Boonen, Kurt [1 ,2 ]
Hoekx, Lucien [4 ]
De Wachter, Stefan [4 ]
Ameye, Filip [5 ]
Mertens, Inge [1 ,2 ]
机构
[1] Flemish Inst Technol Res VITO, Hlth Dept, Mol, Belgium
[2] Univ Antwerp, Ctr Prote, Antwerp, Belgium
[3] Res Inst Chromatog, Kortrijk, Belgium
[4] Antwerp Univ Hosp UZA, Urol Dept, Edegem, Belgium
[5] AZ Maria Middelares Ghent, Urol Dept, Ghent, Belgium
关键词
Extracellular vesicles; urine; variation; size exclusion chromatography; proteomics; lipidomics; LC-MS; MS; power analysis; sample size calculation; biomarker discovery; MEMBRANE-VESICLES; EXOSOMES; CANCER; NORMALIZATION; LIPIDOMICS; PROTEOMICS; TRIGGERS; PLATFORM; CELLS;
D O I
10.1080/20013078.2019.1676035
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Urinary extracellular vesicles (EVs) are an attractive source of biomarkers for urological diseases. A crucial step in biomarker discovery studies is the determination of the variation parameters to perform a sample size calculation. In this way, a biomarker discovery study with sufficient statistical power can be performed to obtain biologically significant biomarkers. Here, a variation study was performed on both the protein and lipid content of urinary EVs of healthy individuals, aged between 52 and 69 years. Ultrafiltration (UF) in combination with size exclusion chromatography (SEC) was used to isolate the EVs from urine. Different experimental variation set-ups were used in this variation study. The calculated standard deviations (SDs) of the 90% least variable peptides and lipids did not exceed 2 and 1.2, respectively. These parameters can be used in a sample size calculation for a well-designed biomarker discovery study at the cargo of EVs.
引用
收藏
页数:10
相关论文
共 44 条
[1]   Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation [J].
Abramowicz, Agata ;
Widlak, Piotr ;
Pietrowska, Monika .
MOLECULAR BIOSYSTEMS, 2016, 12 (05) :1407-1419
[2]   The Yin-Yang of microvesicles (exosomes) in cancer biology [J].
Al-Nedawi, Khalid .
FRONTIERS IN ONCOLOGY, 2014, 4
[3]   Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension? [J].
Barros, Eric R. ;
Carvajal, Cristian A. .
FRONTIERS IN ENDOCRINOLOGY, 2017, 8
[4]   Impact of lower urinary tract symptoms on quality of life using functional assessment cancer therapy scale [J].
Batista-Miranda, Jose E. ;
Molinuevo, Beatriz ;
Pardo, Yolanda .
UROLOGY, 2007, 69 (02) :285-288
[5]   Statistical issues in quality control of proteomic analyses: Good experimental design and planning [J].
Cairns, David A. .
PROTEOMICS, 2011, 11 (06) :1037-1048
[6]   Normalyzer: A Tool for Rapid Evaluation of Normalization Methods for Omics Data Sets [J].
Chawade, Aakash ;
Alexandersson, Erik ;
Levander, Fredrik .
JOURNAL OF PROTEOME RESEARCH, 2014, 13 (06) :3114-3120
[7]   Circulating Extracellular Vesicles in Cancer Diagnosis and Monitoring [J].
Choi, Dong-Sic ;
Lee, Jaewook ;
Go, Gyeongyun ;
Kim, Yoon-Keun ;
Gho, Yong Song .
MOLECULAR DIAGNOSIS & THERAPY, 2013, 17 (05) :265-271
[8]   Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an Interleukin 8-dependent survival of leukemia cells [J].
Corrado, Chiara ;
Raimondo, Stefania ;
Saieva, Laura ;
Flugy, Anna Maria ;
De Leo, Giacomo ;
Alessandro, Riccardo .
CANCER LETTERS, 2014, 348 (1-2) :71-76
[9]   MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification [J].
Cox, Juergen ;
Mann, Matthias .
NATURE BIOTECHNOLOGY, 2008, 26 (12) :1367-1372
[10]  
De Long J, 2015, AM J TRANSL RES, V7, P2500